Post-eradication poliovirus facility-associated community risks

被引:13
|
作者
Dowdle, Walter R.
Wolff, Chris
机构
[1] Task Force Child Survial & Dev, Decatur, GA 30030 USA
[2] WHO, Vaccine Assessment & Monitoring, CH-1211 Geneva 27, Switzerland
关键词
poliovirus containment; community risks; transmission risks; laboratory containment;
D O I
10.1016/j.biologicals.2006.03.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Minimizing the risk of poliovirus transmission from the poliovirus facility to an increasingly susceptible community is crucial when global poliovirus transmission and OPV use stops. Community risks of exposure to wild poliovirus as well as Sabin strains are highest from facility personnel who are unknowingly contaminated or infected. Immunization with OPV or IPV prevents poliomyelitis, but neither vaccine fully inhibits silent infection of the gut. Facility environments maintained at low relative humidity (< 50%) may reduce poliovirus survival and inhalation risk. Circulating antibodies reduce personnel infection risks from injection or virus entry through breaks in skin or mucous membranes. Community exposure risk through inhalation of contaminated air effluent is likely low in most modern facilities. Community risks through ingestion of liquid effluents are facility-specific and may range from high to low. This assessment of community risks, when combined with assessments of facility-specific hazards and the consequences of wild or Sabin poliovirus transmission, provides the foundation for effective risk management. (c) 2006 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 50 条
  • [21] Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection
    Suarez-Bode, Loreto
    Barron, Ruben
    Perez, Jose L.
    Mena, Ana
    ANAEROBE, 2019, 55 : 124 - 129
  • [22] The capacity of public health services to respond to an outbreak in the post-eradication era
    Taylor, CE
    CONSIDERATIONS FOR VIRAL DISEASE ERADICATION, WORKSHOP SUMMARY: LESSONS LEARNED AND FUTURE STRATEGIES, 2002, : 112 - 116
  • [23] Potential use of cytokines and antibody for post-exposure prophylaxis in the post-eradication era
    Griffin, DE
    CONSIDERATIONS FOR VIRAL DISEASE ERADICATION, WORKSHOP SUMMARY: LESSONS LEARNED AND FUTURE STRATEGIES, 2002, : 129 - 133
  • [24] Testing clinical surveillance of acute flaccid paralysis in Egypt post-eradication of poliomyelitis
    Abdel-Mannan, O. A.
    Harris, M. J.
    Parker, J. A.
    Aly, G. S.
    El-Sayed, N. M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (11) : 1395 - 1400
  • [25] High neutrophil-to-lymphocyte ratio at Helicobacter pylori eradication increases the risk of eradication failure and post-eradication gastric cancer
    Yasuda, Takeshi
    Yagi, Nobuaki
    Omatsu, Tatsushi
    Kitae, Hiroaki
    Nakahata, Yuki
    Yasuda, Yuriko
    Sakamoto, Naoyuki
    Obora, Akihiro
    Murakami, Yoshiki
    Kojima, Takao
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (12) : 1277 - 1288
  • [26] Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
    Bandyopadhyay, Ananda S.
    Gast, Chris
    Rivera, Luis
    Saez-Llorens, Xavier
    Oberste, M. Steven
    Weldon, William C.
    Modlin, John
    Clemens, Ralf
    Costa Clemens, Sue Ann
    Jimeno, Jose
    Ruttimann, Ricardo
    LANCET INFECTIOUS DISEASES, 2021, 21 (04): : 559 - 568
  • [27] Risk of rinderpest virus re-introduction 10-years post-eradication
    Kim, Younjung
    Jones, Bryony A.
    Pfeiffer, Dirk U.
    Marrana, Mariana
    Simmons, Heather L.
    Budke, Christine M.
    Fournie, Guillaume
    PREVENTIVE VETERINARY MEDICINE, 2023, 213
  • [28] Dracunculus infection in a dog during the 'post-eradication' period: the need for a longer period of surveillance
    Muhammad, G
    Khan, MZ
    Athar, M
    Saqib, M
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2005, 99 (01): : 105 - 107
  • [29] Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis
    Pliaka, Vaia
    Kyriakopoulou, Zaharoula
    Markoulatos, Panayotis
    EXPERT REVIEW OF VACCINES, 2012, 11 (05) : 609 - 628